コンテンツにスキップ
Where learning shapes lives 25% offWhere learning shapes lives 25% off
25% off all books & eBooks25% off all books & eBooks

Overcoming Barriers to Eliminate Hepatitis C, An Issue of Infectious Disease Clinics of North America, 1st Edition

著者 :
By Camilla S. Graham, MD and Stacey B. Trooskin, MD, PhD
The field of HCV has changed perhaps faster than any other field in medicine. The Guest Editors have strived to create an issue that is a state-of-the-art analysis of solutions to specific challenges faced in the United States and globally in impleme ...view more
The field of HCV has changed perhaps faster than any other field in medicine. The Guest Editors have strived to create an issue that is a state-of-the-art analysis of solutions to specific challenges faced in the United States and globally in implementing HCV elimination strategies. They believe that clinicians now have the tools and road maps needed to accomplish this goal. The clinical review articles in this issue accomplish that: Using Existing Health Care Infrastructure To Expand HCV Care; Creating A Reproducible Health Economic Model To Describe The Burden Of HCV And Cost Of Treatment In Any Country; The Best Uses Of Cost-Effectiveness Models In HCV; Increasing Access To HCV Care In Corrections; Cure As Prevention Strategies For HCV In People Who Inject Drugs; Australia Will Eliminate HCV – How It Works; New York Is The First State In The US To Develop An HCV Elimination Strategy; When HCV Diagnostics Are The Barrier To Care; Key Findings From The Checs HCV Cohort Study; Strategies To Reduce HCV Reinfection Rates In People Who Inject Drugs; Strategies To Reduce HCV Reinfection Rates In Men Who Have Sex With Other Men; The Value Of Curing HCV From A Payer’s Perspective; How To Expand Care Capacity In HCV; Strategies To Eliminate HCV In The HIV Coinfected Population; and The US Veteran’s Administration: Lessons Learned And Best Practices For HCV Elimination.
ISBNコード :
9780323584043
出版日 :
23-05-2018
カートに入れる

!洋書籍は不課税のため消費税不適用、電子書籍は消費税がご注文決済前に表示・適用されます!

!消費税はご注文決済前に表示・適用されます!

The field of HCV has changed perhaps faster than any other field in medicine. The Guest Editors have strived to create an issue that is a state-of-the-art analysis of solutions to specific challenges faced in the United States and globally in implementing HCV elimination strategies. They believe that clinicians now have the tools and road maps needed to accomplish this goal. The clinical review articles in this issue accomplish that: Using Existing Health Care Infrastructure To Expand HCV Care; Creating A Reproducible Health Economic Model To Describe The Burden Of HCV And Cost Of Treatment In Any Country; The Best Uses Of Cost-Effectiveness Models In HCV; Increasing Access To HCV Care In Corrections; Cure As Prevention Strategies For HCV In People Who Inject Drugs; Australia Will Eliminate HCV – How It Works; New York Is The First State In The US To Develop An HCV Elimination Strategy; When HCV Diagnostics Are The Barrier To Care; Key Findings From The Checs HCV Cohort Study; Strategies To Reduce HCV Reinfection Rates In People Who Inject Drugs; Strategies To Reduce HCV Reinfection Rates In Men Who Have Sex With Other Men; The Value Of Curing HCV From A Payer’s Perspective; How To Expand Care Capacity In HCV; Strategies To Eliminate HCV In The HIV Coinfected Population; and The US Veteran’s Administration: Lessons Learned And Best Practices For HCV Elimination.

著者情報
By Camilla S. Graham, MD, Harvard Medical School, Boston, MA and Stacey B. Trooskin, MD, PhD, Drexel University College of Medicine, Philadelphia, PA
詳細情報
ISBN Number 9780323584043
Description Author List By Camilla S. Graham, MD, Harvard Medical School, Boston, MA and Stacey B. Trooskin, MD, PhD, Drexel University College of Medicine, Philadelphia, PA
Copyright Year 2018
Edition Number 1
Format E-Book
Imprint Elsevier
Page Count 0
Publication Date 23 May 2018
Stock Status IN STOCK

Preface: Removing the Barriers from the Path to Eliminate Hepatitis C

Long-Term Liver Disease, Treatment, and Mortality Outcomes Among 17,000 Persons Diagnosed with Chronic Hepatitis C Virus Infection: Current Chronic

Hepatitis Cohort Study Status and Review of Findings

Elimination of Hepatitis C Virus in Australia: Laying the Foundation

Hepatitis C Care in the Department of Veterans Affairs: Building a Foundation for Success 

Localized US Efforts to Eliminate Hepatitis C

New Treatments Have Changed the Game: Hepatitis C Treatment in Primary Care

Five Questions Concerning Managing Hepatitis C in the Justice System: Finding

Practical Solutions for Hepatitis C Virus Elimination

Treatment of Chronic Hepatitis C in Patients Receiving Opioid Agonist Therapy:

A Review of Best Practice

Strategies to Reduce Hepatitis C Virus Reinfection in People Who Inject Drugs 

Understanding and Addressing Hepatitis C Virus Reinfection Among Men Who Have Sex with Men 

Hepatitis C Virus Elimination in the Human Immunodeficiency Virus–Coinfected

Population: Leveraging the Existing Human Immunodeficiency Virus Infrastructure 

Hepatitis C Virus Diagnosis and the Holy Grail

A Guide to the Economics of Hepatitis C Virus Cure in 2017

Estimation of Hepatitis C Disease Burden and Budget Impact of Treatment

Using Health Economic Modeling

The Road to Hepatitis C Virus Cure: Practical Considerations from a Health System’s Perspective

あなたのレビューを投稿する
登録ユーザーのみがレビューを書くことができます。 ログインするか、アカウントを作成してください